Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer

Ingelheim

Sanofi and Boehringer Ingelheim confirmed closing (in most markets) on 1 January 2017 of a $25 billion transaction involving the exchange of Sanofi’s

animal health business and Boehringer Ingelheim’s consumer healthcare business.

Bär

& Karrer acted as Swiss legal advisor to Sanofi. The team included Ralph

Malacrida, Micha Schilling (both M&A), Mani Reinert (Competition), Markus

Wang, and Raffael Nusser (both IP). Weil, Gotshal & Manges LLP acted as

global lead counsel to Sanofi.